FDA Inspection
AltaSciences Clinical Los Angeles Inc.AltaSciences Clinical Los Angeles Inc. – FDA Inspection, Jun 18, 2021
Record Details
This FDA Inspection record concerns AltaSciences Clinical Los Angeles Inc., with an inspection on June 18, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 18, 2021
- Product Type
- Drugs
View Company Profile
ID · b7faa979-974a-458f-bf9c-b68918c5e73c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1144217
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.57(a)Records of receipt, shipment, disposition
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AltaSciences Clinical Los Angeles Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 30, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 4, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 24, 2017 | Not classified | Los Angeles District Office | |
| March 24, 2017 | Not classified | Los Angeles District Office | |
| March 24, 2017 | Not classified | Los Angeles District Office |
Other documents for AltaSciences Clinical Los Angeles Inc.
- FDA Inspection 1174519 - 2022-06-30
- FDA Inspection 1102096 - 2019-09-04
- FDA Inspection 1008799 - 2017-03-24
- FDA Inspection 1008784 - 2017-03-24
- FDA Inspection 1006299 - 2017-03-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.